Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara A Murphy

Showing results (91-100 of 158) with videos related to

Pageof 16
Sort By:
Cancers of the Head & Neck|December 23, 2020
ECOG-ACRIN 2399: analysis of patient related outcomes after Chemoradiation for locally advanced head and neck CancerAnthony Cmelak, Mary S Dietrich, Shuli Li, et al.
Human Brain Mapping|September 26, 2023
Increased microglia activation in late non-central nervous system cancer survivors links to chronic systemic symptomatologyPoppy L A Schoenberg, Alexander K Song, Emily M Mohr, et al.
Genetics|July 29, 2008
Differential gene expression of TRPM1, the potential cause of congenital stationary night blindness and coat spotting patterns (LP) in the Appaloosa horse (Equus caballus)Rebecca R Bellone, Samantha A Brooks, Lynne Sandmeyer, et al.
CA: a Cancer Journal for Clinicians|September 14, 2012
Oral complications of cancer and cancer therapy: from cancer treatment to survivorshipJoel B Epstein, Juliette Thariat, Rene-Jean Bensadoun, et al.
Cancer|March 19, 2016
Using the galactose-α-1,3-galactose enzyme-linked immunosorbent assay to predict anaphylaxis in response to cetuximabJared Weiss, Juneko Grilley Olson, Allison Mary Deal, et al.
Biochimica Et Biophysica Acta|October 3, 2003
GCF2: expression and molecular analysis of repressionToshiki Rikiyama, Joseph Curtis, Masaya Oikawa, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 6, 2009
Longitudinal oncology registry of head and neck carcinoma (LORHAN): initial supportive care findingsBarbara A Murphy, Amy Chen, Walter J Curran, et al.
Medical Oncology (Northwood, London, England)|September 30, 2003
Stratification by risk factors predicts survival on the active treatment arm in a randomized phase II study of interferon-gamma plus/minus interferon-alpha in advanced renal cell carcinoma (E6890)Janice P Dutcher, Jason P Fine, Robert L Krigel, et al.
International Journal of Molecular Medicine|December 7, 2002
Analysis of the epidermal growth factor receptor promoter: the effect of nuclear factor-kappaBHirotaka Nishi, Gila Neta, Katsura H Nishi, et al.
Journal of the National Cancer Institute|July 10, 2014
Recommended patient-reported core set of symptoms to measure in head and neck cancer treatment trialsBhishamjit S Chera, Avraham Eisbruch, Barbara A Murphy, et al.
Pageof 16

Showing results (91-100 of 158) with videos related to

Sort By:
Pageof 16
Cancers of the Head & Neck|December 23, 2020
ECOG-ACRIN 2399: analysis of patient related outcomes after Chemoradiation for locally advanced head and neck CancerAnthony Cmelak, Mary S Dietrich, Shuli Li, et al.
Human Brain Mapping|September 26, 2023
Increased microglia activation in late non-central nervous system cancer survivors links to chronic systemic symptomatologyPoppy L A Schoenberg, Alexander K Song, Emily M Mohr, et al.
Genetics|July 29, 2008
Differential gene expression of TRPM1, the potential cause of congenital stationary night blindness and coat spotting patterns (LP) in the Appaloosa horse (Equus caballus)Rebecca R Bellone, Samantha A Brooks, Lynne Sandmeyer, et al.
CA: a Cancer Journal for Clinicians|September 14, 2012
Oral complications of cancer and cancer therapy: from cancer treatment to survivorshipJoel B Epstein, Juliette Thariat, Rene-Jean Bensadoun, et al.
Cancer|March 19, 2016
Using the galactose-α-1,3-galactose enzyme-linked immunosorbent assay to predict anaphylaxis in response to cetuximabJared Weiss, Juneko Grilley Olson, Allison Mary Deal, et al.
Biochimica Et Biophysica Acta|October 3, 2003
GCF2: expression and molecular analysis of repressionToshiki Rikiyama, Joseph Curtis, Masaya Oikawa, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 6, 2009
Longitudinal oncology registry of head and neck carcinoma (LORHAN): initial supportive care findingsBarbara A Murphy, Amy Chen, Walter J Curran, et al.
Medical Oncology (Northwood, London, England)|September 30, 2003
Stratification by risk factors predicts survival on the active treatment arm in a randomized phase II study of interferon-gamma plus/minus interferon-alpha in advanced renal cell carcinoma (E6890)Janice P Dutcher, Jason P Fine, Robert L Krigel, et al.
International Journal of Molecular Medicine|December 7, 2002
Analysis of the epidermal growth factor receptor promoter: the effect of nuclear factor-kappaBHirotaka Nishi, Gila Neta, Katsura H Nishi, et al.
Journal of the National Cancer Institute|July 10, 2014
Recommended patient-reported core set of symptoms to measure in head and neck cancer treatment trialsBhishamjit S Chera, Avraham Eisbruch, Barbara A Murphy, et al.
Pageof 16